Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 33, 2009 - Issue 5
93
Views
10
CrossRef citations to date
0
Altmetric
PROCEEDINGS 17TH ICOC Shenzhen, PR China, November 2007

Treatment with Deferiprone for Iron Overload Alleviates Bone Marrow Failure in a Fanconi Anemia Patient

, , , , &
Pages 346-351 | Published online: 09 Oct 2009

REFERENCES

  • Bagby GC, Alter BP. Fanconi anemia. Semin Hematol. 2006; 43(3):147–156.
  • Butturini A, Gale RP, Verlander PC, Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood. 1994; 84(5):1650–1655.
  • Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol. 1993; 21(6):731–733.
  • Kutler DI, Singh B, Satagopan J, A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003; 101(4):1249–1256.
  • Collins N, Kupfer GM. Molecular pathogenesis of Fanconi anemia. Int J Hematol. 2005; 82(3):176–183.
  • Levran O, Diotti R, Pujara K, Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study. Hum Mutat. 2005; 25(2):142–149.
  • Tamary H, Dgany O, Toledano H, Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs. Eur J Haematol. 2004; 72(5):330–335.
  • Yagasaki H, Hamanoue S, Oda T, Identification and characterization of novel mutations of the major Fanconi anemia gene FANCA in the Japanese population. Hum Mutat. 2004; 24(6):481–490.
  • Ameziane N, Errami A, Leveille F, Genetic subtyping of Fanconi anemia by comprehensive mutation screening. Hum Mutat. 2008; 29(1):159–166.
  • Bartlett AN, Hoffbrand AV, Kontoghiorghes GJ. Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). II. Clinical observations. Br J Haematol. 1990; 76(2):301–304.
  • Pagano G, Degan P, d'Ischia M, Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype. Eur J Haematol. 2005; 75(2):93–100.
  • Pearl-Yafe M, Halperin D, Scheuerman O, Fabian I. The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. Biochem Pharmacol. 2004; 67(3):539–546.
  • Liu J, Finkel T. Stem cell aging: what bleach can teach. Nat Med. 2006; 12(4):383–384.
  • Ito K, Hirao A, Arai F, Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006; 12(4):446–451.
  • Ito K, Hirao A, Arai F, Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004; 431(7011):997–1002.
  • Zhang X, Sejas DP, Qiu Y, Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence. J Cell Sci. 2007; 120(9):1572–1583.
  • Korkina L, De Luca C, Deeva I, L1 effects on reactive oxygen (ROS) and nitrogen species (RNS) release, hemoglobin oxidation, low molecular weight antioxidants, and antioxidant enzyme activities in red and white blood cells of thalassemic patients. Transfus Sci. 2000; 23(3):253–254.
  • Afanas'ev IB, Afanas'ev II, Deeva IB, Korkina LG. Free radical formation and oxyhemoglobin oxidation in β-thalassemic red blood cells in the presence of prooxidants: effects of the free radical scavenger rutin and oral chelator L1. Transfus Sci. 2000; 23(3):237–238.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.